Brief: India's Gland Pharma Posts Sept-Quarter Consol Net Profit 1.94 Billion Rupees
06/11/2023 10:44
Nov 6 (Reuters) - Gland Pharma Ltd GLAD.NS :
* INDIA'S GLAND PHARMA SEPT-QUARTER CONSOL NET PROFIT 1.94
BILLION
RUPEES VERSUS 2.41 BILLION RUPEES
* GLAND PHARMA SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS
13.73
BILLION RUPEES VERSUS 10.44 BILLION RUPEES
Source text for Eikon: ID:nBSE9Cgdl4
Further company coverage: GLAD.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Gland Pharma
See all newsIndia Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant